CAS 227318-75-4

SM-6586

CAS : 227318-75-4

SM-6586

Degré de pureté : ≥98%

Masse moléculaire : 489.52g/mol

Ref: 54-BUP20589

Sotirimod

CAS : 227318-75-4

Sotirimod（R850） is a novel immunomodulator with antitumor and antiviral activity for the study of actinic keratoses.

Formule : C₁₄H₁₇N₅

Degré de pureté : 95.87%

Couleur et forme : Solid

Masse moléculaire : 255.32

Ref: TM-T16913

Sotirimod

CAS : 227318-75-4

Sotirimod is a monocytic degradable drug that has been shown to be effective in the treatment of skin cancer. It is also used as a diagnostic agent for prostate, colorectal, and breast cancer. Sotirimod binds to fatty acid molecules on the surface of cells. The drug then enters the cell where it forms crosslinks with DNA or RNA, which prevents cell division and replication. This causes cell death by apoptosis. Sotirimod can also be conjugated with affinity ligands such as antibodies or peptides to target specific types of cells.

Formule : C₁₄H₁₇N₅

Degré de pureté : Min. 95%

Masse moléculaire : 255.32 g/mol

Ref: 3D-CJA31875